Solution structure of a beta-peptide ligand for hDM2

Area of Science:

• Biochemistry
• Structural Biology
• Medicinal Chemistry

Background:

• Beta-peptide foldamers are emerging as promising molecules for therapeutic applications.
• The oncoprotein hDM2 and p53 interaction is a key target in cancer therapy.
• Previous work demonstrated beta53-1's ability to bind hDM2 and inhibit p53 interaction.

Purpose of the Study:

• To determine the solution structure of the beta-peptide foldamer beta53-1 in methanol.
• To elucidate the structural basis for beta53-1's folding, stability, and recognition properties.
• To understand how beta53-1 mimics alpha-helices for protein-protein interaction inhibition.

Main Methods:

• Nuclear Magnetic Resonance (NMR) spectroscopy in methanol.
• Computational modeling and structure analysis.

Main Results:

• The solution structure of beta53-1 reveals a stable 14-helix conformation.
• Detailed structural features include a salt bridge network and a unique wedge-into-cleft packing.
• A subtle helical distortion optimizes the presentation of the recognition epitope for alpha-helix mimicry.

Conclusions:

• Beta53-1's structure provides insights into beta-peptide folding and recognition principles.
• The foldamer's unique geometry is well-suited for mimicking alpha-helices and targeting protein interfaces.
• Well-folded beta-peptides offer a versatile platform for developing inhibitors of critical protein-protein interactions.